2013
Core binding factor acute myeloid leukaemia and c-KIT mutations. Oncol Rep. 2013;29(5):1867-72.
Opposing effects of androgen deprivation and targeted therapy on prostate cancer prevention. Cancer Discov. 2013;3(1):44-51.
Evaluation of CINtec PLUS® testing as an adjunctive test in ASC-US diagnosed SurePath® preparations. Diagn Cytopathol. 2013;41(1):35-40.
The integrated landscape of driver genomic alterations in glioblastoma. Nat Genet. 2013;45(10):1141-9.
Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2013;22(12):2354-63.
Control of nutrient stress-induced metabolic reprogramming by PKCζ in tumorigenesis. Cell. 2013;152(3):599-611.
Nonneoplastic renal cortical scarring at tumor nephrectomy predicts decline in kidney function. Arch Pathol Lab Med. 2013;137(4):531-40.
Expression of cyclin d1 and its association with disease characteristics in bladder cancer. Anticancer Res. 2013;33(12):5235-42.
Excellent outcomes with expanded criteria donor kidneys: the role of the recipient's age. Clin Transpl. 2013:85-91.